MYH7 Antibodies

Santa Cruz Biotechnology delivers a wide array of MYH7 monoclonal antibodies for research in muscle biology and related fields. MYH7 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). MYH7, or myosin heavy chain 7, is a critical component of the cardiac muscle contractile apparatus, playing a vital role in muscle contraction and overall heart function. Mutations in the MYH7 gene are associated with various cardiomyopathies, making it an important target for understanding heart diseases and developing therapeutic strategies. The study of MYH7 is essential for elucidating the mechanisms underlying cardiac muscle function and pathology. Researchers can utilize MYH7 monoclonal antibodies to investigate protein expression patterns in different tissue types and experimental conditions. Advanced detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates, enable precise visualization of MYH7 in various experimental settings. Santa Cruz Biotechnology monoclonal antibodies for MYH7 support researchers worldwide in advancing our understanding of cardiovascular health and disease.